載入...
Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin
CONTEXT: Lipodystrophies are extreme forms of metabolic syndrome. Metreleptin was approved in the United States for generalized lipodystrophy (GLD) but not partial lipodystrophy (PLD). OBJECTIVE: The objective of the study was to test metreleptin's efficacy in PLD vs GLD and find predictors for...
Na minha lista:
| 發表在: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Endocrine Society
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4422900/ https://ncbi.nlm.nih.gov/pubmed/25734254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-4491 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|